Most Popular
-
1
[Weekender] Geeks have never been so chic in Korea
![[Weekender] Geeks have never been so chic in Korea](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/16/20240516050845_0.jpg&u=)
-
2
N. Korea says it test-fired tactical ballistic missile with new guidance technology
-
3
NewJeans members submit petitions over court injunction in Hybe-Ador conflict
-
4
[News Focus] Mystery deepens after hundreds of cat deaths in S. Korea
![[News Focus] Mystery deepens after hundreds of cat deaths in S. Korea](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/17/20240517050800_0.jpg&u=)
-
5
S. Korea's exports of instant noodles surpass $100m for 1st time in April: data
![[Weekender] Geeks have never been so chic in Korea](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/16/20240516050845_0.jpg&u=)
![[News Focus] Mystery deepens after hundreds of cat deaths in S. Korea](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/17/20240517050800_0.jpg&u=)
-
6
[Herald Interview] Byun Yo-han's 'unlikable' character is result of calculated acting
![[Herald Interview] Byun Yo-han's 'unlikable' character is result of calculated acting](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/16/20240516050855_0.jpg&u=)
-
7
US military commander in S. Korea during Gwangju uprising dies
-
8
US expert says N. Korea might ignore Trump if he returns to White House
-
9
[Photo News] Seoul seeks 'best sleeper'
![[Photo News] Seoul seeks 'best sleeper'](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/18/20240518050098_0.jpg&u=)
-
10
Yoon vows to advance freedom, welfare to uphold spirit of 1980 pro-democracy uprising
![[Herald Interview] Byun Yo-han's 'unlikable' character is result of calculated acting](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/16/20240516050855_0.jpg&u=)
![[Photo News] Seoul seeks 'best sleeper'](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/18/20240518050098_0.jpg&u=)
[DISCLOSURE] Medipost (078160) announced on Aug. 10 that it has obtained a US patent for administering mesenchymal stem cells derived from umbilical cord blood to treat nerve injuries.
The company said the treatment can be used for curing a number of diseases such as stroke, Alzheimer’s and Lou Gehrig’s disease.
The company said the treatment can be used for curing a number of diseases such as stroke, Alzheimer’s and Lou Gehrig’s disease.
